Modified polypeptides with increased biological activity

Details Modified polypeptides with increased biological activity Modified polypeptides with increased biological activity

1994-03-22

1996-12-03

Fleisher, Mindy

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 12, 514 21, 514814, 530397, 530402, 530408, 530409, 530410, 530411, A61K 3816, A61K 3822, C07K 110, C07K 14505

Patent

active

055808530

ABSTRACT:
Modified polypeptides with increased biological activity exhibited as either increased potency or prolonged circulating half-life are disclosed with methods of preparing the modified polypeptides and methods of use.

REFERENCES:
patent: 4258193 (1981-03-01), Fujii et al.
patent: 4659839 (1987-04-01), Nicolotti et al.
patent: 4677195 (1987-06-01), Hewick et al.
patent: 4797491 (1989-01-01), Nitecki et al.
patent: 4904584 (1990-02-01), Shaw
patent: 5024834 (1991-06-01), Houston et al.
patent: 5066490 (1991-12-01), Neville, Jr. et al.
patent: 5112615 (1992-05-01), Ho et al.
patent: 5116944 (1992-05-01), Sivam et al.
patent: 5134071 (1992-07-01), Gaetjens
patent: 5157123 (1992-10-01), Zora et al.
patent: 5241078 (1993-08-01), Moreland et al.
patent: 5260421 (1993-11-01), Chappel et al.
Singh et al. "Comparison of the Cytotoxic Effect of Hormonotoxins Prepared with the Use of Heterobifunctional Cross-Linking Agents . . . " Bioconjug. Chem 4(6) 473-482 1993.
Peeters et al. "Comparison of of Four Bifunctional Reagents for Coupling Peptides to Proteins . . . "J. Immunol Meth. 120(1) 133-143 1989.
Pierce, "Pierce 1989 Handbook & General Catalog," Pierce Europe B.V., NL, pp. 286-311.
Haniu, M. et al., "Recombinant Human Erythropoietin (rHuEPO): Cross-Linking with Disuccinimidyl Esters and Identification of the Interfacing Domains in EPO," Protein Science, 2:1441-1451 (1993).
Mayeux, P. et al., "Structure of the Murine Erythropoietin Receptor Complex," J. Biol. Chem., 266(34):23380-23385 (1991).
Jung, S. M. and Moroi, M., "Crosslinking of Platelet Glycoprotein Ib By N-Succinimidyl (4-Azidophenyldithio) Propionate and 3,3'-Dithiobis (Sulfosuccinimidyl Propionate)," Biochimica et Biophysica Acta, 761:152-162 (1983).
Chamow, S. M. et al., "Conjugation of Soluble CD4 Without Loss of Biological Activity via a Novel Carbohydrate-Directed Cross-Linking Reagent," J. Biol. Chem., 267(22):15916-15922 (1992).
Carlsson, J. et al., "Protein Thiolation and Reversible Protein-Protein Conjugation," Biochem J., 173:723-737 (1978).
Hashida, S. et al., "More Useful Maleimide Compounds for the Conjugation of Fab' to Horseradish Peroxidase Through Thiol Groups in the Hinge," J. Applied Biochem., 6:56-63 (1984).
Sytkowski, A. J. and Fisher, J. W., "Isolation and Characterization of an Anti-Peptide Monoclonal Antibody to Human Erythropoietin," J. Biol. Chem., 260(27):14727-14731 (1985).
Krystal, G., "A Simple Microassay for Erythropoietin Based on .sup.3 H-Thymidine Incorporation into Spleen Cells from Phenylhydrazine Treated Mice," Hematol., 11(7):649-660 (1983).
Lin, F-K., et al., "Cloning and Expression of the Human Erythropoietin Gene," Proc. Natl. Acac. Sci. USA, 82:7580-7584 (1985).
McDonald, J. D., et al., "Cloning, Sequencing, and Evolutionary Analysis of the Mouse Erythropoietin Gene," Mol. and Cell. Biol., 6:842-848 (1986).
Knusli, C., et al., "Polyethylene Glycol (PEG) Modification of Granulocyte-macrophage Colony Stimulating Factor (GM-CSF) Enhances Neutrophil Priming Activity but Not Colony Stimulating Activity," J. of Hemat., 82:654-663 (1992).
Satake, R., et al., "Chemical Modification of Erythropoietin: An Increase In In Vitro Activity by Guanidination," Biochimica et Biophysica Acta, 1038:125-129 (1990).
Boissel, J-P., et al., "Erythropoietin Structure-Function Relationships," J. Biol. Chem., 268(21):15983-15993 (1993).
Powell, J. S., et al., "Human Erythropoietin Gene: High Level Expression in Stably Transfected Mammalian Cells and Chromosome Localization," Proc. Natl. Acad. Sci. USA, 83:6465-6469 (1986).
Goldwasser, E. and Kung, K-H., "Purification of Erythropoietin," Proc. Natl. Acad. Sci. USA, 68(4):697-698 (1971).
Spivak, J. L. and Hogans, B. B., "The In Vivo Metabolism of Recombinant Human Erythropoietin in the Rat," Blood, 73(1):90-99 (1989).
McMahon, F. G., et al., "Pharmacokinetics and Effects of Recombinant Human Erythropoietin After Intravenous and subcutaneous Injections in Healthy Volunteers," Blood, 76(9):1718-1722 (1990).
Clark, S. and Harrison, L. C., "Disulfide Exchange Between Insulin and its Receptor," J. Biol Chem., 258(19):11434-11437 (1983).
Clark, S. and Harrison, L. C., "Insulin Binding Leads to the Formation of Covalent (--S--S--) Hormone Receptor Complexes," J. Biol. Chem., 257:12239-12344 (1982).
Miyake, T., et al., "Purification of Human Erythropoietin," J. Bio. Chem., 252:5558-5564 (1977).

Affiliated with

Also associated with

Rating

Modified polypeptides with increased biological activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified polypeptides with increased biological activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified polypeptides with increased biological activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-785621